全文获取类型
收费全文 | 118683篇 |
免费 | 12506篇 |
国内免费 | 6461篇 |
专业分类
耳鼻咽喉 | 1217篇 |
儿科学 | 1238篇 |
妇产科学 | 1656篇 |
基础医学 | 31573篇 |
口腔科学 | 3615篇 |
临床医学 | 8225篇 |
内科学 | 15439篇 |
皮肤病学 | 2085篇 |
神经病学 | 8168篇 |
特种医学 | 2446篇 |
外国民族医学 | 42篇 |
外科学 | 10352篇 |
综合类 | 18244篇 |
现状与发展 | 23篇 |
一般理论 | 2篇 |
预防医学 | 3320篇 |
眼科学 | 3835篇 |
药学 | 11277篇 |
26篇 | |
中国医学 | 3436篇 |
肿瘤学 | 11431篇 |
出版年
2024年 | 178篇 |
2023年 | 1403篇 |
2022年 | 2524篇 |
2021年 | 3933篇 |
2020年 | 3807篇 |
2019年 | 3411篇 |
2018年 | 3430篇 |
2017年 | 4038篇 |
2016年 | 4650篇 |
2015年 | 5088篇 |
2014年 | 7591篇 |
2013年 | 9148篇 |
2012年 | 7171篇 |
2011年 | 8287篇 |
2010年 | 6703篇 |
2009年 | 6314篇 |
2008年 | 6704篇 |
2007年 | 6614篇 |
2006年 | 6093篇 |
2005年 | 5223篇 |
2004年 | 4455篇 |
2003年 | 3659篇 |
2002年 | 2798篇 |
2001年 | 2411篇 |
2000年 | 2093篇 |
1999年 | 1797篇 |
1998年 | 1701篇 |
1997年 | 1571篇 |
1996年 | 1411篇 |
1995年 | 1465篇 |
1994年 | 1295篇 |
1993年 | 1147篇 |
1992年 | 944篇 |
1991年 | 906篇 |
1990年 | 765篇 |
1989年 | 743篇 |
1988年 | 638篇 |
1987年 | 572篇 |
1986年 | 518篇 |
1985年 | 757篇 |
1984年 | 658篇 |
1983年 | 458篇 |
1982年 | 572篇 |
1981年 | 454篇 |
1980年 | 381篇 |
1979年 | 327篇 |
1978年 | 236篇 |
1977年 | 188篇 |
1976年 | 156篇 |
1975年 | 67篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
目的 对比研究朝鲜淫羊藿酸性多糖酯化还原前后的理化特性,并探讨其改善油酸诱导的肝癌HepG2细胞脂质堆积活性的差异。方法 采用高效凝胶渗透色谱法测定朝鲜淫羊藿酸性多糖(EFPA)的均一性和分子量,高效液相色谱法测定EFPA和酯化还原后朝鲜淫羊藿酸性多糖(EFPA-R)的单糖组成;采用油酸(OA)处理HepG2细胞诱导建立脂质蓄积模型,不同浓度EFPA与EFPA-R(10、30、100、300 μg·mL-1)分别和OA共同作用于细胞24 h,采用CCK-8试剂盒测定细胞存活率,油红O染色观察细胞内脂滴蓄积情况,并采用试剂盒测定细胞内总胆固醇(TC)、甘油三酯(TG)含量。结果 EFPA为成分均一的多糖组分,分子量为125.8 kDa,由甘露糖、葡萄糖、半乳糖、葡萄糖醛酸和阿拉伯糖组成,摩尔比为1.7∶7.4∶1.4∶1.8∶1.0,葡萄糖占比最大,EFPA-R由甘露糖、葡萄糖、半乳糖和阿拉伯糖组成,摩尔比为0.8∶10.6∶2.1∶1.0;在10-300 μg·mL-1范围内,EFPA和EFPA-R对HepG2细胞的抑制作用较弱,作为给药浓度;与空白组相比,模型组细胞中TC、TG含量显著升高(P < 0.01),细胞内红色脂滴显著增多,与模型组相比,EFPA可显著降低细胞中TC、TG含量(P < 0.01),明显减少细胞内红色脂滴(P < 0.05或P < 0.01),EFPA-R干预后细胞则无明显变化。结论 EFPA可明显改善HepG2细胞脂质堆积情况,且呈现剂量依赖性,而半乳糖醛酸(GalA)的存在可能是其抑制HepG2细胞脂质蓄积的关键因素。 相似文献
2.
《Cancer cell》2022,40(2):153-167.e11
- Download : Download high-res image (229KB)
- Download : Download full-size image
3.
4.
5.
Syed M. Gilani Muhammad Khan Andrea Barbieri Manju L. Prasad 《Diagnostic Histopathology》2021,27(6):263-271
Anaplastic thyroid carcinoma (ATC) is an aggressive thyroid malignancy with high mortality rate. This malignancy arises in thyroid follicular cells either denovo or with an associated differentiated thyroid carcinoma component. Clinically, it usually presents as a rapidly enlarging mass, pain and locally compressive symptoms. Histopathologic variability and heterogeneity often pose diagnostic challenges, especially in scant and paucicellular specimens. This article describes the clinical, histopathologic and molecular features of ATC and also addresses the associated diagnostic limitations and challenges. 相似文献
6.
7.
《Journal of vascular and interventional radiology : JVIR》2021,32(10):1449-1456
PurposeTo investigate the safety and efficacy of thyroid artery embolization (TAE) in the treatment of nodular goiter (NG).MethodsDuring a 5.5-year period, 56 consecutive patients with a NG underwent TAE. In Group A, there were 20 patients with a solitary/dominant 5–11-cm nodule, and in Group B, there were 36 patients with numerous nodules. Of the 56 patients, 47 (84%) had a retrosternal goiter and 25 had hyperthyroidism. In all patients, clinical and radiological evaluations were made at baseline and 6 months after TAE, and these parameters were statistically compared.ResultsIn 56 patients, 145 of the 146 thyroid arteries were successfully embolized. The 30-day mortality rate was 1.8%. Minor and major complications occurred in 25 and 2 patients, respectively. Six months after the TAE, the mean nodule volume was reduced from 80.2 mL to 25.0 mL, the mean thyroid volume was reduced from 147.0 mL to 62.6 mL, and the mean intrathoracic extension was reduced from 31.7 mm to 15.9 mm (P < .001). Of the 22 patients with non–Graves hyperthyroidism, 19 (86%) became euthyroid. The mean thyroid-related patient-reported outcome scores improved from 155.4 to 70.4 (P < .001). Of the 51 patients, 50 (98%) declared that they would recommend TAE to other patients with NG.ConclusionsTAE is safe and effective for the treatment of NG, with a significant volume reduction of the nodule(s) and thyroid gland. 相似文献
8.
Bortezomib is a novel proteasome inhibitor, which has been successfully used to treat mantle cell lymphoma and multiple myeloma. However, the direct effects of bortezomib on acute promyelocytic leukaemia (APL) have not been fully investigated. In the present study, the WST-8 assay, western blotting, flow cytometry, monodansylcadaverine staining and transmission electron microscopy were performed. It was demonstrated that bortezomib treatment induced a time- and dose-dependent decrease in the viability of NB4 cells. Bortezomib treatment induced cell apoptosis in NB4 cells, as assessed by Annexin V/propidium iodide analysis, and the detection of cleaved caspase-3, cleaved poly(ADP-ribose) polymerase, Bax and Bcl-2 expression. Furthermore, bortezomib treatment induced autophagy in NB4 cells, as indicated by autophagosome formation, p62 degradation, LC3-I to LC3-II conversion and formation of acidic autophagic vacuoles. Notably, autophagy induced by bortezomib was initiated prior to apoptosis. Inhibition of autophagy by knocking down Beclin-1 expression increased bortezomib-induced apoptosis in NB4 cells. Therefore, the present study revealed that the combination of bortezomib and autophagy inhibition may be a potential treatment strategy for APL. 相似文献
9.
10.